Report Description

Global Cell Therapy Manufacturing market stood at USD3123.44 million in 2020 and is expected to grow at a steady CAGR of 12.0% during the forecast period. The market growth can be attributed to advancing biopharmaceutical industries, all over the globe. The development of the advancing therapies and transforming paradigm of several life-threatening diseases is driving the growth of the global cell therapy manufacturing market in the upcoming five years. Apart of that growing prevalence of diseases such as cancer, cardiovascular diseases, diabetes, and others is expected to support the growth of the market.

Healthcare industry is involved in the extensive research and technological advancements that leads to the advanced medicine and treatment facilities for the patients. The urgent need for effective therapies as well as a vaccine against the infection supported the exponential growth in the market in the past two years. The market is expected to sustain similar growth in future five years on the same factor. Although the research is consistently growing, the expertise in the sector is limited and the lack of specialized infrastructure to produce cell therapies and various product development may cause a mild restraint on the future growth of the market.

Sudden Outbreak & Spread of COVID-19 Driving Market Growth

Sudden outbreak & spread of COVID-19 drives the growth of cell therapy manufacturing market. Due to COVID-19, a rapid increase in research and development of cell-based vaccines for the treatment of COVID-19 was observed. However, Novartis continued to supply raw materials for cell-based therapies. Many of the raw materials used to manufacture viral vector-based vaccines have been transferred to develop and manufacture what could be billions of doses of COVID-19 vaccines. several biotech organizations took the initiative to examine the virus’s genome to come up with a sustainable vaccine. For instance, in November 2020, Novartis obtained the license for the Mesoblast’s cell therapy Remestemcel-L for the treatment of COVID-19.

Growing Popularity of Regenerative Medicine

Regenerative medicine is still in its infancy, but patient demand and ease of use are growing among healthcare experts. Significant development and advancement in regenerative medicine for the treatment of chronic ailment is driving the growth of cell-based therapies in the market. For example, RepliCel Life Sciences has announced commercialization and clinical testing in projects related to regenerative medicine, including cell-based therapies for skin rejuvenation and tendon regeneration.

Rising Prevalence of Cancer, Cardiac and Other Ailments

There has been a tremendous rise in cardiac cases, cancer ailments, and other diseases since the past decade, resulting in the rising need for cell-based therapies. Many innovative approaches are being developed to repair damaged heart muscle using cell-based therapies. Human retinal pigment epithelium and photoreceptor cells are employed in retinal cell therapy programs for dry age-related macular degeneration (AMD) and inherited retinal diseases (IRDs), which are now in pre-clinical research. Hence, the rising prevalence of diseases contributes to the growth of the cell-based therapies market.

Rising Government Investments in Cell-Based Research

The presence of government and commercial funding agencies that are continually issuing grants to support projects at various phases of clinical trials can be ascribed to the growing number of ongoing clinical studies and the introduction of innovative solutions, boosting the cell therapy manufacturing market. The growing awareness pertaining to health and hygiene has led to an increase in expenditure by different governments across the globe to develop adequate healthcare infrastructure in their countries, leading to the growth and development of new innovative cell-based therapies by various companies and universities.

Click here to download the sample

Market Segmentation

The global Cell Therapy Manufacturing market is segmented based on therapy, source of cell, scale of operation, source, application, end user, company, and regional distribution. Based on therapy, the market is segmented into T-cell therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies. Based on Source of Cell, the market is divided into Autologous and Allogenic. In terms of Scale of Operation, the market can be categorized into Preclinical, Clinical and Commercial. By Source, the market can be fragmented into In-House Manufacturing and Contract Manufacturing. Based on application, the market can be segmented into Oncology, Cardiovascular Diseases, Orthopedic Diseases and Others. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Others.

North America dominates the market of Cell Therapy Manufacturing. United States Cell Therapy Manufacturing Market expected to grow at a CAGR of 12.75% during the Forecast Period.

Company Profiles

Novartis AG, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Thermo Fischer Scientific, Inc., Catalent, Inc., JSR Life Sciences LLC (KBI Biopharma Inc), Waisman Center (Waisman Biomanufacturing), Cell and Gene Therapy Catapult, Merck KGaA, Lonza Group, Oxford Biomedica Plc, WuXi AppTec, Charles River Laboratoires International Inc., Institut Merieux (ABL Inc.), BioCentriq, Centre for Commercialization of Regenerative Medicine (CCRM), Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics), Amgen Inc., Bluebird Bio Inc., Takeda Pharmaceutical Company Limited are among the major market players in the global platform that lead the market growth of the global Cell Therapy Manufacturing market.

Attribute

Details

Market Size Value in 2020

USD 3123.44 Million

Revenue Forecast in 2026

USD 6015.09 Million

United States Market Size value in 2020

USD 870.94 Million

Growth Rate

12.0%

Base Year

2020

Historical Years

2016 – 2019

Estimated Year

2021

Forecast Period

2022 – 2026

Quantitative Units

Revenue in USD Million, and CAGR for 2016-2020 and 2021-2026

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Flavor Type
  • Source of Cell
  • Scale of Operation
  • Source
  • Application
  • End User

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Mexico; Canada; Germany; France; United Kingdom; Spain; Italy; China; Japan; South Korea; Australia; India; Brazil; Argentina; Colombia; Israel; South Africa; Saudi Arabia; UAE

Key Companies Profiled

Novartis AG, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Thermo Fischer Scientific, Inc., Catalent, Inc., JSR Life Sciences LLC (KBI Biopharma Inc), Waisman Center (Waisman Biomanufacturing), Cell and Gene Therapy Catapult, Merck KGaA, Lonza Group, Oxford Biomedica Plc, WuXi AppTec, Charles River Laboratories International Inc., Institut Merieux (ABL Inc.), BioCentriq, Centre for Commercialization of Regenerative Medicine (CCRM), Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics), Amgen Inc., Bluebird Bio Inc., Takeda Pharmaceutical Company Limited

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, global Cell Therapy Manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Cell Therapy Manufacturing Market, By Therapy:
    • T-Cell Therapies
    • Dendritic Cell Therapies
    • Tumor Cell Therapies
    • Stem Cell Therapies
  • Global Cell Therapy Manufacturing Market, By Source of Cell:
    • Autologous
    • Allogenic
  • Global Cell Therapy Manufacturing Market, By Scale of Operation:
    • Preclinical
    • Clinical
    • Commercial
  • Global Cell Therapy Manufacturing Market, By Source:
    • In-House
    • Contract Manufacturing
  • Global Cell Therapy Manufacturing Market, By Application:
    • Oncology
    • Cardiovascular Diseases
    • Orthopedic Diseases
    • Others
  • Global Cell Therapy Manufacturing Market, By End User:
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Others
  • Global Cell Therapy Manufacturing Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • Asia-Pacific
      • China
      • Japan
      • South Korea
      • Australia
      • India
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Israel
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Cell Therapy Manufacturing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of content

1.     Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Cell Therapy Manufacturing Market

5.    Voice of Customers

5.1.  Brand Awareness

5.2.  Commonly Used Cell Therapies

5.3.  Preferences Based on Source of Cell Among Medical Professionals

6.    Global Cell Therapy Manufacturing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)

6.2.2.     By Source of Cell (Autologous v/s Allogenic)

6.2.3.     By Scale of Operation (Preclinical, Clinical, Commercial)

6.2.4.     By Source (In-House v/s Contract Manufacturing)

6.2.5.     By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)

6.2.6.     By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)

6.2.7.     By Company (2020)

6.2.8.     By Region

6.3.  Product Market Map

6.3.1.     By Therapy

6.3.2.     By Scale of Operation

6.3.3.     By Source

6.3.4.     By Application

6.3.5.     By Region

7.    North America Cell Therapy Manufacturing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Therapy

7.2.2.     By Source of Cell

7.2.3.     By Scale of Operation

7.2.4.     By Source

7.2.5.     By Application

7.2.6.     By End User

7.2.7.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Cell Therapy Manufacturing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Therapy

7.3.1.2.2.             By Source of Cell

7.3.1.2.3.             By Scale of Operation

7.3.1.2.4.             By Source

7.3.1.2.5.             By Application

7.3.1.2.6.             By End User

7.3.2.     Canada Cell Therapy Manufacturing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Therapy

7.3.2.2.2.             By Source of Cell

7.3.2.2.3.             By Scale of Operation

7.3.2.2.4.             By Source

7.3.2.2.5.             By Application

7.3.2.2.6.             By End User

7.3.3.     Mexico Cell Therapy Manufacturing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Therapy

7.3.3.2.2.             By Source of Cell

7.3.3.2.3.             By Scale of Operation

7.3.3.2.4.             By Source

7.3.3.2.5.             By Application

7.3.3.2.6.             By End User

8.    Europe Cell Therapy Manufacturing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapy

8.2.2.     By Source of Cell

8.2.3.     By Scale of Operation

8.2.4.     By Source

8.2.5.     By Application

8.2.6.     By End User

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Cell Therapy Manufacturing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Therapy

8.3.1.2.2.             By Source of Cell

8.3.1.2.3.             By Scale of Operation

8.3.1.2.4.             By Source

8.3.1.2.5.             By Application

8.3.1.2.6.             By End User

8.3.2.     France Cell Therapy Manufacturing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Therapy

8.3.2.2.2.             By Source of Cell

8.3.2.2.3.             By Scale of Operation

8.3.2.2.4.             By Source

8.3.2.2.5.             By Application

8.3.2.2.6.             By End User

8.3.3.     United Kingdom Cell Therapy Manufacturing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Therapy

8.3.3.2.2.             By Source of Cell

8.3.3.2.3.             By Scale of Operation

8.3.3.2.4.             By Source

8.3.3.2.5.             By Application

8.3.3.2.6.             By End User

8.3.4.     Spain Cell Therapy Manufacturing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Therapy

8.3.4.2.2.             By Source of Cell

8.3.4.2.3.             By Scale of Operation

8.3.4.2.4.             By Source

8.3.4.2.5.             By Application

8.3.4.2.6.             By End User

8.3.5.     Italy Cell Therapy Manufacturing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Therapy

8.3.5.2.2.             By Source of Cell

8.3.5.2.3.             By Scale of Operation

8.3.5.2.4.             By Source

8.3.5.2.5.             By Application

8.3.5.2.6.             By End User

9.    Asia-Pacific Cell Therapy Manufacturing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Therapy

9.2.2.     By Source of Cell

9.2.3.     By Scale of Operation

9.2.4.     By Source

9.2.5.     By Application

9.2.6.     By End User

9.2.7.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Cell Therapy Manufacturing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Therapy

9.3.1.2.2.             By Source of Cell

9.3.1.2.3.             By Scale of Operation

9.3.1.2.4.             By Source

9.3.1.2.5.             By Application

9.3.1.2.6.             By End User

9.3.2.     Japan Cell Therapy Manufacturing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Therapy

9.3.2.2.2.             By Source of Cell

9.3.2.2.3.             By Scale of Operation

9.3.2.2.4.             By Source

9.3.2.2.5.             By Application

9.3.2.2.6.             By End User

9.3.3.     South Korea Cell Therapy Manufacturing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Therapy

9.3.3.2.2.             By Source of Cell

9.3.3.2.3.             By Scale of Operation

9.3.3.2.4.             By Source

9.3.3.2.5.             By Application

9.3.3.2.6.             By End User

9.3.4.     Australia Cell Therapy Manufacturing Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Therapy

9.3.4.2.2.             By Source of Cell

9.3.4.2.3.             By Scale of Operation

9.3.4.2.4.             By Source

9.3.4.2.5.             By Application

9.3.4.2.6.             By End User

9.3.5.     India Cell Therapy Manufacturing Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Therapy

9.3.5.2.2.             By Source of Cell

9.3.5.2.3.             By Scale of Operation

9.3.5.2.4.             By Source

9.3.5.2.5.             By Application

9.3.5.2.6.             By End User

10.  South America Cell Therapy Manufacturing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Therapy

10.2.2.  By Source of Cell

10.2.3.  By Scale of Operation

10.2.4.  By Source

10.2.5.  By Application

10.2.6.  By End User

10.2.7.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Cell Therapy Manufacturing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Therapy

10.3.1.2.2.           By Source of Cell

10.3.1.2.3.           By Scale of Operation

10.3.1.2.4.           By Source

10.3.1.2.5.           By Application

10.3.1.2.6.           By End User

10.3.2.  Argentina Cell Therapy Manufacturing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Therapy

10.3.2.2.2.           By Source of Cell

10.3.2.2.3.           By Scale of Operation

10.3.2.2.4.           By Source

10.3.2.2.5.           By Application

10.3.2.2.6.           By End User

10.3.3.  Colombia Cell Therapy Manufacturing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Therapy

10.3.3.2.2.           By Source of Cell

10.3.3.2.3.           By Scale of Operation

10.3.3.2.4.           By Source

10.3.3.2.5.           By Application

10.3.3.2.6.           By End User

11.  Middle East and Africa Cell Therapy Manufacturing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Therapy

11.2.2.  By Source of Cell

11.2.3.  By Scale of Operation

11.2.4.  By Source

11.2.5.  By Application

11.2.6.  By End User

11.2.7.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Israel Cell Therapy Manufacturing Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Therapy

11.3.1.2.2.           By Source of Cell

11.3.1.2.3.           By Scale of Operation

11.3.1.2.4.           By Source

11.3.1.2.5.           By Application

11.3.1.2.6.           By End User

11.3.2.  South Africa Cell Therapy Manufacturing Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Therapy

11.3.2.2.2.           By Source of Cell

11.3.2.2.3.           By Scale of Operation

11.3.2.2.4.           By Source

11.3.2.2.5.           By Application

11.3.2.2.6.           By End User

11.3.3.  Saudi Arabia Cell Therapy Manufacturing Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Therapy

11.3.3.2.2.           By Source of Cell

11.3.3.2.3.           By Scale of Operation

11.3.3.2.4.           By Source

11.3.3.2.5.           By Application

11.3.3.2.6.           By End User

11.3.4.  UAE Cell Therapy Manufacturing Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Therapy

11.3.4.2.2.           By Source of Cell

11.3.4.2.3.           By Scale of Operation

11.3.4.2.4.           By Source

11.3.4.2.5.           By Application

11.3.4.2.6.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Clinical Trials

15.  Patent Analysis

16.  Competitive Landscape

16.1.              Competition Outlook

16.2.              Company Profiles (SWOT Analysis of Top 5 Players Profiled)

16.2.1.  Novartis AG

16.2.2.  F.Hoffmann La Roche AG

16.2.3.  Gilead Sciences, Inc.

16.2.4.  Thermo Fischer Scientific, Inc.

16.2.5.  Catalent, Inc.

16.2.6.  JSR Life Sciences LLC (KBI Biopharma Inc)

16.2.7.  Waisman Center (Waisman Biomanufacturing)

16.2.8.  Cell and Gene Therapy Catapult

16.2.9.  Merck KGaA

16.2.10. Lonza Group

16.2.11. Oxford Biomedica Plc

16.2.12. WuXi AppTec

16.2.13. Charles River Laboratories International Inc.

16.2.14. Institut Merieux (ABL Inc.)

16.2.15. BioCentriq

16.2.16. Centre for Commercialization of Regenerative Medicine (CCRM)

16.2.17. Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics)

16.2.18. Amgen Inc.

16.2.19. Bluebird Bio Inc.

16.2.20. Takeda Pharmaceutical Company Limited

17.  Strategic Recommendations

18.  About Us & Disclaimer

Figures and Tables

Figure 1: Global Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 3: Global Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 4: Global Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 5: Global Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 6: Global Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 7: Global Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 8: Global Cell Therapy Manufacturing Market Share, By Region, By Value, 2016-2026F
Figure 9: Global Cell Therapy Manufacturing Market Share, By Company, By Value, 2020
Figure 10: Global Cell Therapy Manufacturing Market Map, By Therapy, Market Size (USD Million) & Growth Rate (%), 2020
Figure 11: Global Cell Therapy Manufacturing Market Map, By Scale of Operations, Market Size (USD Million) & Growth Rate (%), 2020
Figure 12: Global Cell Therapy Manufacturing Market Map, By Source, Market Size (USD Million) & Growth Rate (%), 2020
Figure 13: Global Cell Therapy Manufacturing Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2020
Figure 14: Global Cell Therapy Manufacturing Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2020
Figure 15: North America Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 16: North America Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 17: North America Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 18: North America Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 19: North America Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 20: North America Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 21: North America Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 22: North America Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 23: United States Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 24: United States Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 25: United States Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 26: United States Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 27: United States Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 28: United States Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 29: United States Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 30: Canada Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 31: Canada Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 32: Canada Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 33: Canada Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 34: Canada Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 35: Canada Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 36: Canada Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 37: Mexico Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 38: Mexico Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 39: Mexico Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 40: Mexico Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 41: Mexico Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 42: Mexico Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 43: Mexico Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 44: Europe Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 45: Europe Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 46: Europe Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 47: Europe Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 48: Europe Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 49: Europe Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 50: Europe Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 51: Europe Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 52: Germany Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 53: Germany Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 54: Germany Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 55: Germany Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 56: Germany Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 57: Germany Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 58: Germany Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 59: France Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 60: France Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 61: France Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 62: France Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 63: France Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 64: France Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 65: France Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 66: United Kingdom Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 67: United Kingdom Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 68: United Kingdom Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 69: United Kingdom Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 70: United Kingdom Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 71: United Kingdom Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 72: United Kingdom Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 73: Spain Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 74: Spain Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 75: Spain Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 76: Spain Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 77: Spain Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 78: Spain Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 79: Spain Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 80: Italy Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 81: Italy Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 82: Italy Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 83: Italy Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 84: Italy Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 85: Italy Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 86: Italy Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 87: Asia Pacific Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 88: Asia Pacific Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 89: Asia Pacific Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 90: Asia Pacific Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 91: Asia Pacific Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 92: Asia Pacific Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 93: Asia Pacific Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 94: Asia Pacific Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 95: China Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 96: China Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 97: China Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 98: China Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 99: China Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 100: China Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 101: China Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 102: Japan Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 103: Japan Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 104: Japan Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 105: Japan Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 106: Japan Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 107: Japan Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 108: Japan Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 109: South Korea Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 110: South Korea Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 111: South Korea Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 112: South Korea Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 113: South Korea Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 114: South Korea Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 115: South Korea Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 116: Australia Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 117: Australia Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 118: Australia Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 119: Australia Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 120: Australia Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 121: Australia Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 122: Australia Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 123: India Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 124: India Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 125: India Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 126: India Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 127: India Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 128: India Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 129: India Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 130: South America Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 131: South America Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 132: South America Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 133: South America Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 134: South America Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 135: South America Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 136: South America Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 137: South America Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 138: Brazil Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 139: Brazil Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 140: Brazil Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 141: Brazil Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 142: Brazil Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 143: Brazil Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 144: Brazil Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 145: Argentina Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 146: Argentina Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 147: Argentina Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 148: Argentina Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 149: Argentina Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 150: Argentina Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 151: Argentina Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 152: Colombia Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 153: Colombia Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 154: Colombia Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 155: Colombia Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 156: Colombia Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 157: Colombia Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 158: Colombia Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 159: Middle East & Africa Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 160: Middle East & Africa Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 161: Middle East & Africa Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 162: Middle East & Africa Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 163: Middle East & Africa Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 164: Middle East & Africa Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 165: Middle East & Africa Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 166: Middle East & Africa Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 167: Israel Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 168: Israel Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 169: Israel Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 170: Israel Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 171: Israel Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 172: Israel Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 173: Israel Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 174: South Africa Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 175: South Africa Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 176: South Africa Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 177: South Africa Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 178: South Africa Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 179: South Africa Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 180: South Africa Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 181: Saudi Arabia Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 182: Saudi Arabia Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 183: Saudi Arabia Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 184: Saudi Arabia Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 185: Saudi Arabia Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 186: Saudi Arabia Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 187: Saudi Arabia Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 188: UAE Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 189: UAE Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 190: UAE Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 191: UAE Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 192: UAE Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 193: UAE Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 194: UAE Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 195: Clinical Trials Studies on Cell Therapy Manufacturing from 2016 & 2020
Figure 196: Number of Cell Therapy Manufacturing Patents Application and Granted Patents from 2016-2021
Figure 197: Number of Cell Therapy Manufacturing Patents Filled, Granted, Published from 2016-2021 (November)
Figure 198: Cell Therapy Manufacturing Patents Legal Status from 2020-2021 (November)
Figure 199: Percentage of Patents Applicants vs Owners in 2021

List of Tables:
Table 1: Number of Persons Aged 65 Years or Above by Geographic Region, 2019 and 2050
Table 2: Clinically Approved Cell Therapies
Table 3: Clinical Trial Studies on Cell Therapy Manufacturing till November 2021
Table 4: List of Some Recent Patents in Cell Therapy Manufacturing

Frequently asked questions

down-arrow

Europe Cell Therapy Manufacturing market is driven by the growing awareness among the population coupled with increasing oncology and cardiovascular diseases especially in the countries like United Kingdom, Germany, among others. Furthermore, various government and commercial funding agencies that are continually issuing grants to support projects at various phases of clinical trials can be ascribed to the growing number of ongoing clinical studies and the introduction of innovative solutions. Also, the European region was significantly affected by pandemic crisis especially the countries like Spain and Italy, which in turn increased the demand for cell therapy-based vaccine for COVID-19.

down-arrow

MEA Region expected to grow at a CAGR of 10.84% during the forecast period. Israel followed by South Africa, Saudi Arabia and UAE are the prominent countries for cell therapy manufacturing research & development in the region. The expansion of major market players such as Lonza Group, Novartis AG, among others in the region especially in countries like Israel, Saudi Arabia and UAE is expected to create lucrative opportunities for the market growth. According to the WHO, Saudi Arabia is home to the second largest diabetic population in the region. Besides, supportive government policies and regulatory scenario in the region along with increasing expenditures by different governments especially by the governments of Saudi Arabia and UAE is expected to create lucrative opportunities for the market growth in the region.

down-arrow

The major factors slowing down the growth of Global Cell Therapy Manufacturing Market include high cost of cellular therapies, large scale manufacturing of the cell therapy-based products, dearth of skilled healthcare professionals, stringent regulatory policies and lack of awareness.

down-arrow

The major trends in Cell Therapy Manufacturing Market include manufacturing of cell therapy inside the cell shuttle, stem cell-mediated suicide gene therapy, direct cell reprogramming, engineering natural killer cells for car t-cell therapy, stem cell-based therapies for treatment of diabetes and stem cells as delivery vehicles for oncolytic viruses.

profile

Sakshi Bajaal

Business Consultant
Press Release

Cell Therapy Manufacturing Market to Grow at a Steady CAGR of 12.0% During the Forecast Period

Dec, 2021

Consistent research and studies are driving the growth in Global Cell therapy manufacturing Market in the forecast period, 2022-2026.